Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 33,152 | 26,074 | 18,303 | 8,650 | 23,337 |
| Depreciation Amortization | 4,490 | 3,586 | 2,443 | 1,205 | 3,043 |
| Income taxes - deferred | 6,745 | 5,432 | 2,906 | 1,160 | 6,189 |
| Accounts receivable | -2,469 | -11,484 | -7,064 | -1,483 | -3,767 |
| Accounts payable and accrued liabilities | 3,040 | 860 | 888 | -5,272 | 3,759 |
| Other Working Capital | 2,737 | -10,295 | -3,745 | -6,014 | 4,317 |
| Other Operating Activity | 16,519 | 23,434 | 14,479 | 10,947 | 14,897 |
| Operating Cash Flow | $64,214 | $37,607 | $28,210 | $9,193 | $51,775 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -552 | -418 | -428 | -130 | -1,795 |
| Purchase Of Investment | -420,461 | -315,187 | -197,352 | -93,060 | -346,622 |
| Sale Of Investment | 344,317 | 264,907 | 163,670 | 93,261 | 306,918 |
| Investing Cash Flow | $-76,696 | $-50,698 | $-34,110 | $71 | $-41,499 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,550 | 2,509 | 2,138 | 1,849 | 5,634 |
| Financing Cash Flow | $3,550 | $2,509 | $2,138 | $1,849 | $5,634 |
| Exchange Rate Effect | -91 | 10 | -29 | -15 | 53 |
| Beginning Cash Position | 61,613 | 61,613 | 61,613 | 61,613 | 45,650 |
| End Cash Position | 52,590 | 51,041 | 57,822 | 72,711 | 61,613 |
| Net Cash Flow | $-9,023 | $-10,572 | $-3,791 | $11,098 | $15,963 |
| Free Cash Flow | |||||
| Operating Cash Flow | 64,214 | 37,607 | 28,210 | 9,193 | 51,775 |
| Capital Expenditure | -552 | -418 | -428 | -130 | -1,795 |
| Free Cash Flow | 63,662 | 37,189 | 27,782 | 9,063 | 49,980 |